BML Investment Partners, L.P. - 26 Feb 2025 SCHEDULE 13G Report for LAVA Therapeutics N.V. Common shares, par value $0.14 per share (LVTX)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: LAVA Therapeutics N.V. Common shares, par value $0.14 per share
Symbol: LVTX
Shares outstanding: 26,460,946 shares
Disclosed Ownership: 1,958,110 shares
Ownership: 7.4%
Form type: SCHEDULE 13G
Filing time: 03 Mar 2025, 14:03:50 UTC
Date of event: 26 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	7.4%	1,958,110	0	1,958,110	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member